Page 114 - MEMORIA ANUAL 2021
P. 114

   MEMORIA ANUAL 2021 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
GESMD
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
  • Co-occurrence of cohesin complex and Ras signalling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia. Haematologica. 2021 Aug 1;106(8):2215-23. doi: 10.3324/haematol.2020.248807. Martín-Izquierdo M, Abáigar M, Hernández-Sánchez JM, Tamborero D, López-Cadenas F, Ramos F, Lumbreras E, Madinaveitia-Ochoa A, Megido M, Labrador J, Sánchez-Real J, Olivier C, Dávila J, Aguilar C, Rodríguez JN, Martín-Núñez G, Santos-Mínguez S, Miguel- García C, Benito R, Díez-Campelo M, Hernández-Rivas JM .
• A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS.
Blood Adv. 2021 Aug 24;5(16):3066-75. doi: 10.1182/bloodadvances.2020004055. Oster HS, Crouch S, Smith A, Yu G, Abu Shrkihe B, Baruch S, Kolomansky A, Ben-Ezra J, Naor S, Fenaux P, Symeonidis A, Stauder R, Cermak J, Sanz G, Hellström-Lindberg E, Malcovati L, Langemeijer S, Germing U, Holm MS, Madry K, Guerci-Bresler A, Culligan D, Sanhes L, Mills J, Kotsianidis I, van Marrewijk C, Bowen D, de Witte T, Mittelman M .
• Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
J Clin Oncol. 2021 Apr 10;39(11):1223-33. doi: 10.1200/JCO.20.01659.
Bersanelli M, Travaglino E, Meggendorfer M, Matteuzzi T, Sala C, Mosca E, Chiereghin C, Di Nanni N, Gnocchi M, Zampini M, Rossi M, Maggioni G, Termanini A, Angelucci E, Bernardi M, Borin L, Bruno B, Bonifazi F, Santini V, Bacigalupo A, Voso MT, Oliva E, Riva M, Ubezio M, Morabito L, Campagna A, Saitta C, Savevski V, Giampieri E, Remondini D, Passamonti F, Ciceri F, Bolli N, Rambaldi A, Kern W, Kordasti S, Sole F, Palomo L, Sanz G, Santoro A, Platzbecker U, Fenaux P, Milanesi L, Haferlach T, Castellani G, Della Porta MG .
• Outcomes of patients with chronic myelomonocytic leukaemia treated with non-cu- rative therapies: a retrospective cohort study.
Lancet Haematol. 2021 Feb;8(2):e135-e148. doi: 10.1016/S2352-3026(20)30374-4. Pleyer L, Leisch M, Kourakli A, Padrón E, Maciejewski JP, Xicoy Cirici B, Kaivers J, Ungers- tedt J, Heibl S, Patiou P, Hunter AM, Mora E, Geissler K, Dimou M, Jiménez Lorenzo MJ, Melchardt T, Egle A, Viniou AN, Patel BJ, Arnán M, Valent P, Roubakis C, Bernal del Castillo T, Galanopoulos A, Calabuig Muñoz M, Bonadies N, Medina de Almeida A, Cermak J, Je- rez A, Montoro MJ, Cortés A, Avendaño Pita A, López Andrade B, Hellstroem-Lindberg E, Germing U, Sekeres MA, List AF, Symeonidis A, Sanz GF, Larcher-Senn J, Greil R .
• Cryopreservation of Allogeneic Hematopoietic Progenitor Cells in The Current SARS- Cov-2 Pandemic: Experience of A Single Centre.
Bone Marrow Transplant. 2021;56(Suppl 1):97-98.
 114
 



















































































   112   113   114   115   116